Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

NCT07497399 · PHASE2 · RECRUITING · Sponsor: Johns Hopkins University · Conditions: Multiple

By Priya Raman · Science Reporter

Nov 5 07:00 ETSource: ClinicalTrials.gov

From the source

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
NCT07497399 · PHASE2 · RECRUITING · Sponsor: Johns Hopkins University · Conditions: Multiple Sclerosis.

Read at clinicaltrials.gov

Source URL https://clinicaltrials.gov/study/NCT07497399